Last reviewed · How we verify

NCT04213027

RCT for SSLF vs. ISFF With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients

Status unknown NA Last updated 2 January 2020
What this trial tests

NA trial testing native tissue repair procedures with conventional surgical instruments in Apical Prolapse in 320 participants. Status unknown.

Timeline
1 January 2020
Primary endpoint
31 December 2022
31 December 2025

Quick facts

Lead sponsorPeking Union Medical College Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment320
Start date1 January 2020
Primary completion31 December 2022
Estimated completion31 December 2025
Sites5 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking Union Medical College Hospital

Who can join

Eligibility, female only, with Apical Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is designed to investigate the efficacy and safety of two native tissue repair procedure with conventional surgical instruments in Chinese apical prolapse female patients (POP-Q II-IV) and compare the outcome in prolapse women randomized to Sacrospinous ligament fixation (SSLF) and Ischial spinous fascia fixation (ISFF).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Apical Prolapse

Currently open trials in the same condition.

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04213027.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing